Lakeshore Biopharma (NASDAQ:LSB – Get Free Report) is expected to issue its quarterly earnings data before the market opens on Monday, January 27th. Analysts expect Lakeshore Biopharma to post earnings of ($0.80) per share for the quarter.
Lakeshore Biopharma Trading Up 12.9 %
NASDAQ:LSB opened at $2.63 on Friday. The company has a fifty day moving average of $2.86. The company has a debt-to-equity ratio of 0.13, a quick ratio of 0.90 and a current ratio of 1.17. Lakeshore Biopharma has a one year low of $1.88 and a one year high of $11.20.
About Lakeshore Biopharma
See Also
- Five stocks we like better than Lakeshore Biopharma
- Using the MarketBeat Stock Split Calculator
- Why Energy Transfer Stock Could Soar to New Highs in 2025
- How to Read Stock Charts for Beginners
- 3 Buy-and-Hold Stocks for Long-Term Growth
- What is Insider Trading? What You Can Learn from Insider Trading
- Despite Short-Term Risks Freeport McMoran Worth a Look
Receive News & Ratings for Lakeshore Biopharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Lakeshore Biopharma and related companies with MarketBeat.com's FREE daily email newsletter.